More than 200,000 people are diagnosed with melanoma every year in the U.S. In fact, melanoma is the least common diagnosed type of skin cancer and the most deadly. Through advancements in treatment, including immunotherapy, people are living longer.
Dr. Roy Jensen, director and vice chancellor of The University of Kansas Cancer Center, will speak with Drs. Gary Doolittle and Luke Selby about the newest advances in melanoma research and therapy, and how they will affect those in our community suffering from this disease. They will also discuss risks and prevention, including what you should be looking for in a suncreen to prevent skin cancer. In addition, we will hear from a patient who will share his melanoma story.
